Chengliang Yang
Providence Health Care(CA)University of British Columbia(CA)Aluminum Corporation of China (China)(CN)St. Paul's Hospital(CA)First Affiliated Hospital of Xi'an Jiaotong University(CN)First Affiliated Hospital of GuangXi Medical University(CN)Prevention of Organ Failure(CA)Affiliated Hospital of Youjiang Medical University for Nationalities(CN)St. Paul's Hospital(CA)Southern Medical University(CN)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, Lung Cancer Diagnosis and Treatment, SARS-CoV-2 and COVID-19 Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Curcumin Blocks Small Cell Lung Cancer Cells Migration, Invasion, Angiogenesis, Cell Cycle and Neoplasia through Janus Kinase-STAT3 Signalling Pathway(2012)218 cited
- → Nano-Modified Titanium Implant Materials: A Way Toward Improved Antibacterial Properties(2020)120 cited
- → Cellular and molecular biomarkers of long COVID: a scoping review(2023)100 cited
- → Curcumin Induces Small Cell Lung Cancer NCI-H446 Cell Apoptosis via the Reactive Oxygen Species-Mediated Mitochondrial Pathway and Not the Cell Death Receptor Pathway(2011)85 cited
- → Retracted: Down‐regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA‐145‐mediated inhibition of FSCN1(2019)71 cited
- → Fibronectin 1 activates WNT/β-catenin signaling to induce osteogenic differentiation via integrin β1 interaction